Madrid, Spain

Isabel Digon Juarez

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignee: Pharma Mar, S.a.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isabel Digon Juarez. Retrieved from https://idiyas.com/inventor/isabel-digon-juarez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Isabel Digon Juarez: Innovator in Antitumoral Compounds

Introduction

Isabel Digon Juarez is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and development of antitumoral compounds. With a total of 2 patents, her work is paving the way for new therapeutic options in oncology.

Latest Patents

Isabel's latest patents focus on antitumoral compounds, specifically a compound of general formula (I) wherein A, Y, R, R, R, R, R, and R take various meanings or uses in the treatment of cancer. This groundbreaking research aims to provide more effective solutions for patients battling cancer.

Career Highlights

Isabel is currently employed at Pharma Mar, S.A., a company known for its commitment to developing innovative therapies for cancer treatment. Her work at Pharma Mar has allowed her to explore new avenues in pharmaceutical research, contributing to the advancement of cancer therapies.

Collaborations

Isabel collaborates with esteemed colleagues such as Alberto Rodriquez Vicente and Maria Garranzo Garcia-Ibarrola. These partnerships enhance her research efforts and foster a collaborative environment for innovation in cancer treatment.

Conclusion

Isabel Digon Juarez is a trailblazer in the field of antitumoral research, with her patents reflecting her dedication to improving cancer therapies. Her contributions are vital in the ongoing fight against cancer, and her work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…